Framework for community-based models for treating hepatitis C virus.

ConclusionThis framework for understanding the components of models of community-based HCV treatment may be used as a guide for designing, implementing and evaluating models of care in support of HCV elimination. HCV care providers and patients need to be supported to improve their engagement with the provision of community-based treatment. In addition, evidence-based strategies to facilitate service delivery need to be included.What is known about the topic?Community-based models for treating HCV are widely recognised as having the advantage of reaching more people who require treatment. These types of models aim to remove barriers related to accessibility and acceptability associated with tertiary centre-based HCV treatment.What does this paper add?Community-based models for treating HCV use various organisational and operational elements to improve the accessibility, effectiveness and acceptability of these services. The elements we identified target three main domains: support for patients with HCV, support for HCV care providers and service delivery facilitation. The importance of these organisational and operational elements designed to improve health and health services outcomes of community-based models for treating HCV is strongly influenced by context, and dependent on both the setting and target population.What are the implications for practitioners?Health policy makers and practitioners need to consider a patient's psychosocial and economic status and provide supp...
Source: Australian Health Review - Category: Hospital Management Authors: Tags: Aust Health Rev Source Type: research

Related Links:

Publication date: Available online 21 February 2020Source: Journal of Clinical and Experimental HepatologyAuthor(s): Kellie Young, Benny Liu, Taft Bhuket, Robert J. WongAbstractBackground &AimsDirect-acting antivirals (DAAs) are expected to improve outcomes for hepatitis C virus (HCV) patients following liver transplantation (LT). We aim to evaluate trends in post-LT outcomes with availability of DAAs.MethodsWe retrospectively evaluated U.S. adults transplanted from 1/1/2002 – 3/31/2018 using the United Network for Organ Sharing registry, stratified by pre-DAA (1/1/2002-12/31/2013) vs. post-DAA (1/1/2014-3/31/201...
Source: Journal of Clinical and Experimental Hepatology - Category: Gastroenterology Source Type: research
Publication date: April 2020Source: Cancer Epidemiology, Volume 65Author(s): Ahmed Arafa, Ehab S. Eshak, Tarek A. Abdel Rahman, Manal M. AnwarAbstractBackgroundA growing body of evidence has suggested an association between Hepatitis C virus (HCV) infection and risk of pancreatic cancer (PAC). Herein, we conducted a meta-analysis of available evidence to explore this association.MethodsWe systematically retrieved studies that investigated the association between HCV infection and risk of PAC. Pooled odds ratio (OR) with corresponding 95 % confidence interval (CI) of PAC for patients with HCV infection was calculated using ...
Source: Cancer Epidemiology - Category: Cancer & Oncology Source Type: research
An estimated 4.1 million people in the United States are infected with hepatitis C virus (HCV). In 2014, the Hepatitis C Community Alliance to Test and Treat (HepCCATT) collaborative was formed to address hepatitis C in Chicago. From 2014 to 2017, the HepCCATT Case Management Program case managed 181 HCV-infected people and performed on-site capacity building at a 6-site community health center (CHC) that produced codified protocols, which were translated into a telehealth program to build capacity within CHCs to deliver hepatitis C care. HepCCATT's innovative approach to addressing multilevel barriers is a potential model...
Source: Family and Community Health - Category: Primary Care Tags: Original Articles Source Type: research
ConclusionsThe incidence of HCC and progression of liver disease was evident in PR responders during the long-term follow-up period, but the risk level was low. Cirrhotic responders were more vulnerable to develop HCC post SVR24 compared with non-cirrhotic ones. HCV recurrence was rare in responders with SVR24 who had corrected their risky behaviors.
Source: Hepatobiliary and Pancreatic Diseases International - Category: Gastroenterology Source Type: research
NPs should be given a more significant role in this effort.
Source: AJN - Category: Nursing Tags: Viewpoint Source Type: research
Source: Clinical and Experimental Gastroenterology - Category: Gastroenterology Tags: Clinical and Experimental Gastroenterology Source Type: research
In Belgium, people who inject drugs (PWID) are at a high risk of being infected by hepatitis C (HCV) as injecting drug use is the main mode for transmission of HCV in Europe. Estimates about the number of peop...
Source: Harm Reduction Journal - Category: Drugs & Pharmacology Authors: Tags: Research Source Type: research
Conclusions: The level of knowledge of HCV is suboptimal, and the self-reported testing rate for HCV is less than 10%; however, once HCV infection is diagnosed, the treatment rate seems to be high in South Korea. More active campaigns and effective screening are needed. PMID: 32066209 [PubMed - as supplied by publisher]
Source: Gut and Liver - Category: Gastroenterology Tags: Gut Liver Source Type: research
We report the median and 95% uncertainty interval (UI) from 1151 modelled runs.FindingsOne-time screening of 90% of the 2018 population by 2030, with 80% referral to treatment, was projected to lead to 13·8 million (95% UI 13·4–14·1) individuals being screened and 350 000 (315 000–385 000) treatments started annually, decreasing hepatitis C incidence by 26·5% (22·5–30·7) over 2018–30. Prioritised screening of high prevalence groups (PWID and adults aged ≥30 years) and rescreening (annually for PWID, otherwise every 10 years) are likely to increase t...
Source: The Lancet Global Health - Category: International Medicine & Public Health Source Type: research
Publication date: March 2020Source: The Lancet Global Health, Volume 8, Issue 3Author(s): Zaigham Abbas, Minaam Abbas
Source: The Lancet Global Health - Category: International Medicine & Public Health Source Type: research
More News: Australia Health | Databases & Libraries | Education | Hepatitis | Hepatitis C | Hospital Management | Men | Psychology | Study